Legal and ethical status of stem cells as medicinal products.
The realisation of the full potential of products based on stem cells in a clinical setting demands robust scientific evidence, underpinned by legitimate regulatory requirements to ensure their safety and efficacy. This review examines the legal aspects of the use of stem cells in the laboratory and in the development of new therapies and pharmaceutical products. UK and European legal and regulatory documents and directives are used as the framework for discussion of the current status and future prospects.
Tsang
Lincoln
L
Arnold & Porter LLP, Tower 42, 25 Old Broad Street, London, EC2N 4HQ, United Kingdom. Lincoln.Tsang@aporter.com
D000818:Animals; D004992:Ethics, Medical; D005060:Europe; D033161:Government Regulation; D006291:Health Policy / Q000331:legislation & jurisprudence*; D006801:Humans; D033581:Stem Cell Transplantation / Q000941:ethics / Q000331:legislation & jurisprudence; D013234:Stem Cells